The success rate of gene drug development

1. As of July, 2023 18, Alnylam statistics show that the success rate of new drug research and development in biomedical industry is 5.5%, the average success rate of targeted drugs is 10, and the success rate of Alnylam can reach 54.6%.

2. Acrolein Aniram Pharmaceutical Company. The company name AlnylamPharmaceuticals, Inc. was listed on May 28th, 2004, and the exchange is Nasdaq Stock Exchange.